Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in a woman with eosinophilia-myalgia syndrome improved after stopping L-tryptophan and starting treatment.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Pregnancy can cause various skin changes, including pigmentation, acne, and stretch marks, and may affect preexisting skin conditions.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

Stopping the use of fluocinolone oil containing balsam fragrance improved hair regrowth in children allergic to it.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Sexual activity can spread T. interdigitale, needing quick antifungal treatment to avoid permanent scarring.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

The document concludes that secondary syphilis cases are increasing and often misdiagnosed, pityriasis rubra pilaris can be distinguished from psoriasis by skin cell features, and different skin layers produce specific components during skin repair.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Erosive pustular dermatosis in elderly people may be linked to aging immune systems and skin damage.

A 54-year-old man with painful skin blisters and fever was diagnosed with Sweet syndrome and successfully treated with corticosteroids.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

A 16-year-old girl's skin rash was likely caused by an infection and improved with topical steroids.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Most patients with small patches of hair loss usually regrow hair.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Acne can appear or persist in adulthood due to hormonal changes, external factors, or substance use, and requires appropriate treatment.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.